Abstract
Summary
The global Agomelatine Tablets market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Agomelatine Tablets Industry Forecast” looks at past sales and reviews total world Agomelatine Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Agomelatine Tablets sales for 2024 through 2030. With Agomelatine Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Agomelatine Tablets industry.
This Insight Report provides a comprehensive analysis of the global Agomelatine Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Agomelatine Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Agomelatine Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Agomelatine Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Agomelatine Tablets.
United States market for Agomelatine Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Agomelatine Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Agomelatine Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Agomelatine Tablets players cover Servier, Rovi Pharma, Novartis, Nectid and Jiangsu Haosen Pharmaceutical Group. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Agomelatine Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Serotonin 2C Agonist
Melatonin Receptor 2 Agonist
Melatonin Receptor 1 Agonist
Serotonin Receptor Agonist
Serotonin 2C Receptor Antagonist
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Servier
Rovi Pharma
Novartis
Nectid
Jiangsu Haosen Pharmaceutical Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Agomelatine Tablets market?
What factors are driving Agomelatine Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Agomelatine Tablets market opportunities vary by end market size?
How does Agomelatine Tablets break out type, application?
LP Information, Inc. (LPI) ' newest research report, the “Agomelatine Tablets Industry Forecast” looks at past sales and reviews total world Agomelatine Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Agomelatine Tablets sales for 2024 through 2030. With Agomelatine Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Agomelatine Tablets industry.
This Insight Report provides a comprehensive analysis of the global Agomelatine Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Agomelatine Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Agomelatine Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Agomelatine Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Agomelatine Tablets.
United States market for Agomelatine Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Agomelatine Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Agomelatine Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Agomelatine Tablets players cover Servier, Rovi Pharma, Novartis, Nectid and Jiangsu Haosen Pharmaceutical Group. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Agomelatine Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Serotonin 2C Agonist
Melatonin Receptor 2 Agonist
Melatonin Receptor 1 Agonist
Serotonin Receptor Agonist
Serotonin 2C Receptor Antagonist
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Servier
Rovi Pharma
Novartis
Nectid
Jiangsu Haosen Pharmaceutical Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Agomelatine Tablets market?
What factors are driving Agomelatine Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Agomelatine Tablets market opportunities vary by end market size?
How does Agomelatine Tablets break out type, application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Agomelatine Tablets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Agomelatine Tablets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Agomelatine Tablets by Country/Region, 2019, 2023 & 2030
2.2 Agomelatine Tablets Segment by Type
2.2.1 Serotonin 2C Agonist
2.2.2 Melatonin Receptor 2 Agonist
2.2.3 Melatonin Receptor 1 Agonist
2.2.4 Serotonin Receptor Agonist
2.2.5 Serotonin 2C Receptor Antagonist
2.3 Agomelatine Tablets Sales by Type
2.3.1 Global Agomelatine Tablets Sales Market Share by Type (2019-2024)
2.3.2 Global Agomelatine Tablets Revenue and Market Share by Type (2019-2024)
2.3.3 Global Agomelatine Tablets Sale Price by Type (2019-2024)
2.4 Agomelatine Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Agomelatine Tablets Sales by Application
2.5.1 Global Agomelatine Tablets Sale Market Share by Application (2019-2024)
2.5.2 Global Agomelatine Tablets Revenue and Market Share by Application (2019-2024)
2.5.3 Global Agomelatine Tablets Sale Price by Application (2019-2024)
3 Global Agomelatine Tablets by Company
3.1 Global Agomelatine Tablets Breakdown Data by Company
3.1.1 Global Agomelatine Tablets Annual Sales by Company (2019-2024)
3.1.2 Global Agomelatine Tablets Sales Market Share by Company (2019-2024)
3.2 Global Agomelatine Tablets Annual Revenue by Company (2019-2024)
3.2.1 Global Agomelatine Tablets Revenue by Company (2019-2024)
3.2.2 Global Agomelatine Tablets Revenue Market Share by Company (2019-2024)
3.3 Global Agomelatine Tablets Sale Price by Company
3.4 Key Manufacturers Agomelatine Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Agomelatine Tablets Product Location Distribution
3.4.2 Players Agomelatine Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Agomelatine Tablets by Geographic Region
4.1 World Historic Agomelatine Tablets Market Size by Geographic Region (2019-2024)
4.1.1 Global Agomelatine Tablets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Agomelatine Tablets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Agomelatine Tablets Market Size by Country/Region (2019-2024)
4.2.1 Global Agomelatine Tablets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Agomelatine Tablets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Agomelatine Tablets Sales Growth
4.4 APAC Agomelatine Tablets Sales Growth
4.5 Europe Agomelatine Tablets Sales Growth
4.6 Middle East & Africa Agomelatine Tablets Sales Growth
5 Americas
5.1 Americas Agomelatine Tablets Sales by Country
5.1.1 Americas Agomelatine Tablets Sales by Country (2019-2024)
5.1.2 Americas Agomelatine Tablets Revenue by Country (2019-2024)
5.2 Americas Agomelatine Tablets Sales by Type
5.3 Americas Agomelatine Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Agomelatine Tablets Sales by Region
6.1.1 APAC Agomelatine Tablets Sales by Region (2019-2024)
6.1.2 APAC Agomelatine Tablets Revenue by Region (2019-2024)
6.2 APAC Agomelatine Tablets Sales by Type
6.3 APAC Agomelatine Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Agomelatine Tablets by Country
7.1.1 Europe Agomelatine Tablets Sales by Country (2019-2024)
7.1.2 Europe Agomelatine Tablets Revenue by Country (2019-2024)
7.2 Europe Agomelatine Tablets Sales by Type
7.3 Europe Agomelatine Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Agomelatine Tablets by Country
8.1.1 Middle East & Africa Agomelatine Tablets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Agomelatine Tablets Revenue by Country (2019-2024)
8.2 Middle East & Africa Agomelatine Tablets Sales by Type
8.3 Middle East & Africa Agomelatine Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Agomelatine Tablets
10.3 Manufacturing Process Analysis of Agomelatine Tablets
10.4 Industry Chain Structure of Agomelatine Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Agomelatine Tablets Distributors
11.3 Agomelatine Tablets Customer
12 World Forecast Review for Agomelatine Tablets by Geographic Region
12.1 Global Agomelatine Tablets Market Size Forecast by Region
12.1.1 Global Agomelatine Tablets Forecast by Region (2025-2030)
12.1.2 Global Agomelatine Tablets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Agomelatine Tablets Forecast by Type
12.7 Global Agomelatine Tablets Forecast by Application
13 Key Players Analysis
13.1 Servier
13.1.1 Servier Company Information
13.1.2 Servier Agomelatine Tablets Product Portfolios and Specifications
13.1.3 Servier Agomelatine Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Servier Main Business Overview
13.1.5 Servier Latest Developments
13.2 Rovi Pharma
13.2.1 Rovi Pharma Company Information
13.2.2 Rovi Pharma Agomelatine Tablets Product Portfolios and Specifications
13.2.3 Rovi Pharma Agomelatine Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Rovi Pharma Main Business Overview
13.2.5 Rovi Pharma Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Agomelatine Tablets Product Portfolios and Specifications
13.3.3 Novartis Agomelatine Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Nectid
13.4.1 Nectid Company Information
13.4.2 Nectid Agomelatine Tablets Product Portfolios and Specifications
13.4.3 Nectid Agomelatine Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Nectid Main Business Overview
13.4.5 Nectid Latest Developments
13.5 Jiangsu Haosen Pharmaceutical Group
13.5.1 Jiangsu Haosen Pharmaceutical Group Company Information
13.5.2 Jiangsu Haosen Pharmaceutical Group Agomelatine Tablets Product Portfolios and Specifications
13.5.3 Jiangsu Haosen Pharmaceutical Group Agomelatine Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Jiangsu Haosen Pharmaceutical Group Main Business Overview
13.5.5 Jiangsu Haosen Pharmaceutical Group Latest Developments
14 Research Findings and Conclusion